Health-economic impact of implementing continuous vital sign monitoring in post-surgical patients in five European countries.

Jasjit Syan^1,2, Tobias Muench³, Carla Fernández-Barceló³, Rhodri Saunders³, Jonah Attebery⁴, Marco Luchetti⁵, Mary Erslon⁶, John Beard⁴, Sadia Khan^1,2

¹Department of Cardiology, Chelsea and Westminster NHS Foundation Trust, London, United Kingdom.

²National Heart and Lung Institute, Imperial College of London, London, United Kingdom.

³Department of Health Economics, Coreva Scientific GmbH & Co. KG, Koenigswinter, Germany.

⁴Patient Care Solutions, GE HealthCare, Chicago, IL, USA.

⁵Patient Care Solutions, GE HealthCare, Milano, Italy.

⁶Mary Erslon LLC, St. Louis, MO, USA.

PubMed DOI

Abstract

AIMS: Hospitals, in particular intensive care units (ICUs), account for a large proportion of healthcare costs and environmental burden. Preventing unexpected patient transfer to ICU via continuous vital sign monitoring (CVSM) may mitigate this burden. Country-specific evidence on the cost-effectiveness of CVSM is missing. This analysis explored the impact of CVSM versus intermittent monitoring in…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.